-
1
-
-
84858210437
-
-
American Geriatrics Society. n.d, Retrieved September 30
-
American Geriatrics Society. n.d. "Underrepresentation of Older Adults in Clinical Trials: Issue Brief." www.americangeriatrics.org/files/ documents/Older-Adults-in-Clinical-Trials-FINAL.pdf. Retrieved September 30, 2011.
-
(2011)
Underrepresentation of Older Adults in Clinical Trials: Issue Brief
-
-
-
2
-
-
42949112210
-
Treatment of hypertension in patients 80 years of age or older
-
DOI 10.1056/NEJMoa0801369
-
Beckett, N. S., et al. 2008. "Treatment of Hypertension in Patients 80 Years of Age or Older New England." Journal of Medicine 358(18): 1887-98. (Pubitemid 351620109)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.18
, pp. 1887-1898
-
-
Beckett, N.S.1
Peters, R.2
Fletcher, A.E.3
Staessen, J.A.4
Liu, L.5
Dumitrascu, D.6
Stoyanovsky, V.7
Antikainen, R.L.8
Nikitin, Y.9
Anderson, C.10
Belhani, A.11
Forette, F.12
Rajkumar, C.13
Thijs, L.14
Banya, W.15
Bulpitt, C.J.16
-
3
-
-
0030802061
-
Explicit criteria for determining potentially inappropriate medication use by the elderly an update
-
Beers, M. H. 1997. "Explicit Criteria for Determining Potentially Inappropriate Medication Use by the Elderly." Archives of Internal Medicine 157(14): 1531-6. (Pubitemid 27305197)
-
(1997)
Archives of Internal Medicine
, vol.157
, Issue.14
, pp. 1531-1536
-
-
Beers, M.H.1
-
4
-
-
84858210434
-
-
Center for Medicines and Healthy Aging, Retrieved September 29, 2011
-
Center for Medicines and Healthy Aging. 2011. "Questions to Ask Your Doctor or Pharmacist About Your Medication." www.medsandaging.org/tools/ questionstoask.cfm. Retrieved September 29, 2011.
-
(2011)
Questions to Ask Your Doctor or Pharmacist about Your Medication
-
-
-
5
-
-
79955162230
-
The persistent exclusion of older patients from ongoing clinical trials regarding heart failure
-
Cherubini, A., et al. 2011. "The Persistent Exclusion of Older Patients from Ongoing Clinical Trials Regarding Heart Failure." Archives of Internal Medicine 171(6): 550-6.
-
(2011)
Archives of Internal Medicine
, vol.171
, Issue.6
, pp. 550-556
-
-
Cherubini, A.1
-
6
-
-
33750328584
-
-
Committee on Identifying and Preventing Medication Errors, Washington, D.C.: National Academies Press
-
Committee on Identifying and Preventing Medication Errors. 2007. Preventing Medication Errors: Quality Chasm Series. Washington, D.C.: National Academies Press.
-
(2007)
Preventing Medication Errors: Quality Chasm Series
-
-
-
7
-
-
1842784019
-
Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: A consensus report
-
DOI 10.1111/j.1532-5415.2004.52174.x
-
Ferrucci, L., et al. 2004. "Designing Randomized, Controlled Trials Aimed at Preventing or Delaying Functional Decline and Disability in Frail, Older Persons: A Consensus Report." Journal of the American Geriatrics Society 52(4): 625-34. (Pubitemid 38480644)
-
(2004)
Journal of the American Geriatrics Society
, vol.52
, Issue.4
, pp. 625-634
-
-
Ferrucci, L.1
Guralnik, J.M.2
Studenski, S.3
Fried, L.P.4
Cutler Jr., G.B.5
Walston, J.D.6
-
8
-
-
0345600187
-
Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults: Results of a US Consensus Panel of Experts
-
DOI 10.1001/archinte.163.22.2716
-
Fick, D. M., et al. 2003. "Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults." Archives of Internal Medicine 163(22): 2716-24. (Pubitemid 37517412)
-
(2003)
Archives of Internal Medicine
, vol.163
, Issue.22
, pp. 2716-2724
-
-
Fick, D.M.1
Cooper, J.W.2
Wade, W.E.3
Waller, J.L.4
Maclean, J.R.5
Beers, M.H.6
-
9
-
-
3843146052
-
Risk factors for adverse drug events among older adults in the ambulatory setting
-
DOI 10.1111/j.1532-5415.2004.52367.x
-
Field, T. S., et al. 2004. "Risk Factors for Adverse Drug Events Among Older Adults in the Ambulatory Setting." Journal of the American Geriatrics Society 52(8): 1349-54. (Pubitemid 39038210)
-
(2004)
Journal of the American Geriatrics Society
, vol.52
, Issue.8
, pp. 1349-1354
-
-
Field, T.S.1
Gurwitz, J.H.2
Harrold, L.R.3
Rothschild, J.4
DeBellis, K.R.5
Seger, A.C.6
Auger, J.C.7
Garber, L.A.8
Cadoret, C.9
Fish, L.S.10
Garber, L.D.11
Kelleher, M.12
Bates, D.W.13
-
11
-
-
0024244678
-
Drug-associated hospital admissions in older medical patients
-
Grymonpre, R. E., et al. 1988. "Drug-Associated Hospital Admissions in Older Medical Patients." Journal of the American Geriatrics Society 36(12): 1092-8. (Pubitemid 19005050)
-
(1988)
Journal of the American Geriatrics Society
, vol.36
, Issue.12
, pp. 1092-1098
-
-
Grymonpre, R.E.1
Mitenko, P.A.2
Sitar, D.S.3
Aoki, F.Y.4
Montgomery, P.R.5
-
12
-
-
0026808530
-
A method for assessing drug therapy appropriateness
-
Hanlon, J. T., et al. 1992. "A Method for Assessing Drug Therapy Appropriateness." Journal of Clinical Epidemiology 45(10): 1045-51.
-
(1992)
Journal of Clinical Epidemiology
, vol.45
, Issue.10
, pp. 1045-1051
-
-
Hanlon, J.T.1
-
14
-
-
0005706058
-
The impact of an interdisciplinary team on suboptimal prescribing in a long-term care facility
-
Jeffery, S. M., et al. 1999. "The Impact of an Interdisciplinary Team on Suboptimal Prescribing in a Long-Term Care Facility." Consultant Pharmacist 14(12): 1386-9.
-
(1999)
Consultant Pharmacist
, vol.14
, Issue.12
, pp. 1386-1389
-
-
Jeffery, S.M.1
-
17
-
-
77953574621
-
STOPP & START criteria: A new approach to detecting potentially inappropriate prescribing in old age
-
O'Mahony, D., et al. 2010. "STOPP & START Criteria: A New Approach to Detecting Potentially Inappropriate Prescribing in Old Age." European Geriatric Medicine 1(1): 45-51.
-
(2010)
European Geriatric Medicine
, vol.1
, Issue.1
, pp. 45-51
-
-
O'mahony, D.1
-
19
-
-
77958577146
-
Lipidlowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds
-
Petersen, L. K., Christensen, K., and Kragstrup, J. 2010. "Lipidlowering Treatment to the End? A Review of Observational Studies and RCTs on Cholesterol and Mortality in 80+-Year Olds." Age and Ageing 39: 674-80.
-
(2010)
Age and Ageing
, vol.39
, pp. 674-680
-
-
Petersen, L.K.1
Christensen, K.2
Kragstrup, J.3
-
20
-
-
0037417238
-
Memantine in moderate-to-severe Alzheimer's disease
-
DOI 10.1056/NEJMoa013128
-
Reisberg, B., et al. 2003. "Memantine in Moderate-to-Severe Alzheimer's Disease New England." Journal of Medicine 348(14): 1333-41. (Pubitemid 36384100)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.14
, pp. 1333-1341
-
-
Reisberg, B.1
Doody, R.2
Stoffler, A.3
Schmitt, F.4
Ferris, S.5
Mobius, H.J.6
-
21
-
-
34948883290
-
Quality indicators for medication use in vulnerable elders
-
DOI 10.1111/j.1532-5415.2007.01345.x
-
Shrank, W. H., Polinski, J. M., and Avorn, J. 2007. "Quality Indicators for Medication Use in Vulnerable Elders." Journal of the American Geriatrics Society 55(S2): S373-82. (Pubitemid 47515348)
-
(2007)
Journal of the American Geriatrics Society
, vol.55
, Issue.SUPPL. 2
-
-
Shrank, W.H.1
Polinski, J.M.2
Avorn, J.3
-
22
-
-
0002106918
-
What is pharmacoepidemiology?
-
Strom, B. L., and Kimmel, S. E., eds. (4th ed). West Sussex, England and John Wiley and Sons, Ltd.
-
Strom, B. L. 2006. "What Is Pharmacoepidemiology?" In Strom, B. L., and Kimmel, S. E., eds., Textbook of Pharmacoepidemiology (4th ed). West Sussex, England: John Wiley and Sons, Ltd.
-
(2006)
Textbook of Pharmacoepidemiology
-
-
Strom, B.L.1
-
23
-
-
0345872128
-
Memantine treatment in patients with moderate to severe alzheimer disease already receiving donepezil: A randomized controlled trial
-
DOI 10.1001/jama.291.3.317
-
Tariot, P. N., et al. 2004. "Memantine Treatment in Patients with Moderate to Severe Alzheimer Disease Already Receiving Donepezil: A Randomized Controlled Trial." Journal of the American Medical Association 291(3): 317-24. (Pubitemid 38101604)
-
(2004)
Journal of the American Medical Association
, vol.291
, Issue.3
, pp. 317-324
-
-
Tariot, P.N.1
Farlow, M.R.2
Grossberg, G.T.3
Graham, S.M.4
McDonald, S.5
Gergel, I.6
-
24
-
-
70350239875
-
The medical letter on drugs and therapeutics
-
The Medical Letter on Drugs and Therapeutics. 2009. "Generic Drugs Revisited." Issue 1323: 81.
-
(2009)
Generic Drugs Revisited
, vol.1323
, pp. 81
-
-
-
25
-
-
84858256069
-
-
U.S. Food and Drug Administration. Retrieved September 29, 2011
-
U.S. Food and Drug Administration. 2010. "Disposal of Unused Medicine: What You Should Know." www.fda.gov/drugs/resourcesforyou/ consumers/buyingusingmedicinesafely/ensuringsafeuseofmedicine/ safedisposalofmedicines/ucm186187.htm. Retrieved September 29, 2011.
-
(2010)
Disposal of Unused Medicine: What You Should Know
-
-
-
26
-
-
79959542542
-
Benefit-risk assessment: To quantify or not to quantify, that is the question
-
Yuan, Z., Levitan, B., and Berlin, J. A. 2011. "Benefit-Risk Assessment: To Quantify or Not to Quantify, That Is the Question." Pharmacoepidemiology and Drug Safety 20(6): 653-6.
-
(2011)
Pharmacoepidemiology and Drug Safety
, vol.20
, Issue.6
, pp. 653-656
-
-
Yuan, Z.1
Levitan, B.2
Berlin, J.A.3
|